Original Article
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
Reducción de la actividad de la enfermedad, el uso de corticosteroides y recursos sanitarios en pacientes con lupus eritematoso sistémico tratados con belimumab en práctica clínica real: estudio multicéntrico OBSErve España
Josefina Cortés-Hernándeza,
, Carlos Marras Fernández-Cidb, Jose Luis Andreu Sánchezc, Jaime Calvo Alénd, Angel M. García-Aparicioe, Elvira Díez Álvarezf, Francisco Javier Hidalgo Bermejog,1, Carlos Coronellh, Alessandra Pernai,1, Josep Ordi Rosa
Corresponding author
a Rheumatology Department, Hospital Vall d’Hebron, Barcelona, Spain
b Rheumatology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
c Rheumatology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
d Rheumatology Department, Hospital Universitario de Araba, Vitoria, Spain
e Rheumatology Department, Hospital Universitario de Toledo, Toledo, Spain
f Rheumatology Department, Hospital Universitario de León, León, Spain
g Medical Department, GSK, Madrid, Spain
h Primary Care Medical Center of Vallirana, Barcelona, Spain, formerly Medical Department, GSK, Madrid, Spain
i Specialty Franchise, GSK, London, UK
Ver másRead
2289
Timeswas read the article
845
Total PDF
1444
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 12 | 17 |
| 2025 5 | 149 | 66 | 215 |
| 2025 4 | 123 | 35 | 158 |
| 2025 3 | 77 | 40 | 117 |
| 2025 2 | 76 | 37 | 113 |
| 2025 1 | 94 | 77 | 171 |
| 2024 12 | 73 | 41 | 114 |
| 2024 11 | 65 | 67 | 132 |
| 2024 10 | 41 | 61 | 102 |
| 2024 9 | 59 | 29 | 88 |
| 2024 8 | 62 | 52 | 114 |
| 2024 7 | 64 | 43 | 107 |
| 2024 6 | 90 | 57 | 147 |
| 2024 5 | 96 | 56 | 152 |
| 2024 4 | 97 | 33 | 130 |
| 2024 3 | 57 | 35 | 92 |
| 2024 2 | 56 | 38 | 94 |
| 2024 1 | 97 | 35 | 132 |
| 2023 12 | 61 | 28 | 89 |
| 2023 11 | 1 | 3 | 4 |
| 2023 7 | 1 | 0 | 1 |
Show all
